Background: The assessment of Quality of Life (QoL) is a Medical goal; it is used in clinical research, medical practice, health-related economic studies and in planning health management measures and strategies. The objective of this project is to develop an informational platform to achieve a patient self-assessment with standardized QoL measuring instruments, through friendly software, easy for the user to adapt, which should aid the study of QoL, by promoting the creation of databases and accelerating its statistical treatment and yet generating subsequent useful results in graphical format for the physician analyzes in an appointment immediately after the answers collection.
Methods: First, a software platform was designed and developed in an action-research process with patients, physicians and nurses. The computerized patient self-assessment with standardized QoL measuring instruments was compared with traditional one, to verify if its use did not influence the patient's answers. For that, the Wilcoxon and t-Student tests were applied. After, we adopted and adapted the mathematic Rash model to make possible the use of QoL measure in the routine appointments.
Results: The results show that the computerized patient self-assessment does not influence the patient's answers and can be used as a suitable tool in the routine appointment, because indicates problems which are more difficult to identify in a traditional appointment, improving thus the physician's decisions.
Conclusions: The possibility of representing graphically useful results that physician needs to analyze in the appointment, immediately after the answer collection, in an useful time, makes this QoL assessment platform a diagnosis instrument ready to be used routinely in clinical practice.
{"title":"A decision support system for quality of life in head and neck oncology patients.","authors":"Joaquim J Gonçalves, Alvaro M Rocha","doi":"10.1186/1758-3284-4-3","DOIUrl":"https://doi.org/10.1186/1758-3284-4-3","url":null,"abstract":"<p><strong>Background: </strong>The assessment of Quality of Life (QoL) is a Medical goal; it is used in clinical research, medical practice, health-related economic studies and in planning health management measures and strategies. The objective of this project is to develop an informational platform to achieve a patient self-assessment with standardized QoL measuring instruments, through friendly software, easy for the user to adapt, which should aid the study of QoL, by promoting the creation of databases and accelerating its statistical treatment and yet generating subsequent useful results in graphical format for the physician analyzes in an appointment immediately after the answers collection.</p><p><strong>Methods: </strong>First, a software platform was designed and developed in an action-research process with patients, physicians and nurses. The computerized patient self-assessment with standardized QoL measuring instruments was compared with traditional one, to verify if its use did not influence the patient's answers. For that, the Wilcoxon and t-Student tests were applied. After, we adopted and adapted the mathematic Rash model to make possible the use of QoL measure in the routine appointments.</p><p><strong>Results: </strong>The results show that the computerized patient self-assessment does not influence the patient's answers and can be used as a suitable tool in the routine appointment, because indicates problems which are more difficult to identify in a traditional appointment, improving thus the physician's decisions.</p><p><strong>Conclusions: </strong>The possibility of representing graphically useful results that physician needs to analyze in the appointment, immediately after the answer collection, in an useful time, makes this QoL assessment platform a diagnosis instrument ready to be used routinely in clinical practice.</p>","PeriodicalId":49195,"journal":{"name":"Head and Neck Optical Diagnostics Society","volume":"4 ","pages":"3"},"PeriodicalIF":0.0,"publicationDate":"2012-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1758-3284-4-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30465834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anandi H W Schiphorst, Bas A Twigt, Sjoerd G Elias, Thijs van Dalen
Background: In thyroid surgery vessel division and haemostasis make up an important and time consuming part of the operation. While the presence of the recurrent laryngeal nerve limits the liberal use of diathermia, the many arterial and venous branches to and from the thyroid gland necessitates the use of numerous conventional suture ligatures.This study evaluates the effect of using a vessel sealing system on operation time during thyroid surgery.
Methods: A randomized clinical trial was performed between September 2005 and October 2008 in a teaching hospital. Forty patients undergoing total hemithyroidectomy participated in the trial. Twenty were randomized to the intraoperative use of the LigaSure Precise™ vessel sealing system, and twenty to the use of conventional suture ligatures.
Results: The total median operation time was 10 minutes shorter in the LigaSure group (56 versus 66 minutes, P = 0.001). No significant differences in complications were noticed.
Conclusion: Using an electrothermal vessel sealing system during thyroid surgery is time saving.
Trial registration: This trial was registered in the international standard randomized controlled trials number register (ISRCTNR) under number ISRCTNR82389535.
{"title":"Randomized clinical trial of LigaSure versus conventional suture ligation in thyroid surgery.","authors":"Anandi H W Schiphorst, Bas A Twigt, Sjoerd G Elias, Thijs van Dalen","doi":"10.1186/1758-3284-4-2","DOIUrl":"https://doi.org/10.1186/1758-3284-4-2","url":null,"abstract":"<p><strong>Background: </strong>In thyroid surgery vessel division and haemostasis make up an important and time consuming part of the operation. While the presence of the recurrent laryngeal nerve limits the liberal use of diathermia, the many arterial and venous branches to and from the thyroid gland necessitates the use of numerous conventional suture ligatures.This study evaluates the effect of using a vessel sealing system on operation time during thyroid surgery.</p><p><strong>Methods: </strong>A randomized clinical trial was performed between September 2005 and October 2008 in a teaching hospital. Forty patients undergoing total hemithyroidectomy participated in the trial. Twenty were randomized to the intraoperative use of the LigaSure Precise™ vessel sealing system, and twenty to the use of conventional suture ligatures.</p><p><strong>Results: </strong>The total median operation time was 10 minutes shorter in the LigaSure group (56 versus 66 minutes, P = 0.001). No significant differences in complications were noticed.</p><p><strong>Conclusion: </strong>Using an electrothermal vessel sealing system during thyroid surgery is time saving.</p><p><strong>Trial registration: </strong>This trial was registered in the international standard randomized controlled trials number register (ISRCTNR) under number ISRCTNR82389535.</p>","PeriodicalId":49195,"journal":{"name":"Head and Neck Optical Diagnostics Society","volume":"4 ","pages":"2"},"PeriodicalIF":0.0,"publicationDate":"2012-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1758-3284-4-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30397047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Oral and pharyngeal cancers are the sixth most common cancers internationally. In the United States, there are about 30,000 new cases of oral and pharyngeal cancers diagnosed each year. Furthermore, survival rates for oral and pharyngeal cancers have not significantly improved over the last three decades. This review examines the scientific literature surrounding the epidemiology of oral and pharyngeal cancers, including but not limited to risk factors, disparities, preventative factors, and the epidemiology in countries outside the United States. The literature review revealed that much of the research in this field has been focused on alcohol, tobacco, and their combined effects on oral and pharyngeal cancers. The literature on oral and pharyngeal cancer disparities among racial groups also appears to be growing. However, less literature is available on the influence of dietary factors on these cancers. Finally, effective interventions for the reduction of oral and pharyngeal cancers are discussed.
{"title":"A review of the epidemiology of oral and pharyngeal carcinoma: update.","authors":"Daniel M Saman","doi":"10.1186/1758-3284-4-1","DOIUrl":"https://doi.org/10.1186/1758-3284-4-1","url":null,"abstract":"<p><p>Oral and pharyngeal cancers are the sixth most common cancers internationally. In the United States, there are about 30,000 new cases of oral and pharyngeal cancers diagnosed each year. Furthermore, survival rates for oral and pharyngeal cancers have not significantly improved over the last three decades. This review examines the scientific literature surrounding the epidemiology of oral and pharyngeal cancers, including but not limited to risk factors, disparities, preventative factors, and the epidemiology in countries outside the United States. The literature review revealed that much of the research in this field has been focused on alcohol, tobacco, and their combined effects on oral and pharyngeal cancers. The literature on oral and pharyngeal cancer disparities among racial groups also appears to be growing. However, less literature is available on the influence of dietary factors on these cancers. Finally, effective interventions for the reduction of oral and pharyngeal cancers are discussed.</p>","PeriodicalId":49195,"journal":{"name":"Head and Neck Optical Diagnostics Society","volume":"4 ","pages":"1"},"PeriodicalIF":0.0,"publicationDate":"2012-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1758-3284-4-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30386080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Lanzer, W. Zemann, T. Lübbers, A. Kruse, S. Reinisch
OBJECTIVES: Oral and oropharyngeal squamous cell carcinoma puts the patient at risk for bilateral neck lymph node metastasis. For this reason, routine bilateral neck dissection is preferred by some surgeons as the treatment of choice, even in N0-necks, despite the morbidity of this procedure. METHODS: Utilising data of 496 patients with squamous cell carcinoma of the head and neck region treated at the Department of Otorhinolaryngology and Head and Neck at the Medical University Hospital, Graz from 1999 to 2009, we retrospectively evaluated the effect of bilateral neck dissection on recurrence-free and overall survival rates in patients with oral and oropharyngeal cancer. RESULTS: Long-term survival of 152 patients with oral and oropharyngeal cancer did not show a statistical benefit of elective contralateral neck dissection in patients with contralateral clinically negative neck. Neither locoregional recurrence-free survival nor overall survival rates differed. CONCLUSION: We could not find a statistical benefit for operating on patients with oral and oropharyngeal squamous cell carcinoma with an elective neck dissection in contralateral clinically negative neck.
{"title":"Do patients with oral and oropharyngeal squamous cell carcinoma benefit from elective contralateral neck dissection? A long-term analysis","authors":"M. Lanzer, W. Zemann, T. Lübbers, A. Kruse, S. Reinisch","doi":"10.5167/UZH-70818","DOIUrl":"https://doi.org/10.5167/UZH-70818","url":null,"abstract":"OBJECTIVES: Oral and oropharyngeal squamous cell carcinoma puts the patient at risk for bilateral neck lymph node metastasis. For this reason, routine bilateral neck dissection is preferred by some surgeons as the treatment of choice, even in N0-necks, despite the morbidity of this procedure. METHODS: Utilising data of 496 patients with squamous cell carcinoma of the head and neck region treated at the Department of Otorhinolaryngology and Head and Neck at the Medical University Hospital, Graz from 1999 to 2009, we retrospectively evaluated the effect of bilateral neck dissection on recurrence-free and overall survival rates in patients with oral and oropharyngeal cancer. RESULTS: Long-term survival of 152 patients with oral and oropharyngeal cancer did not show a statistical benefit of elective contralateral neck dissection in patients with contralateral clinically negative neck. Neither locoregional recurrence-free survival nor overall survival rates differed. CONCLUSION: We could not find a statistical benefit for operating on patients with oral and oropharyngeal squamous cell carcinoma with an elective neck dissection in contralateral clinically negative neck.","PeriodicalId":49195,"journal":{"name":"Head and Neck Optical Diagnostics Society","volume":"4 1","pages":"70"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70660208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-01-01Epub Date: 2012-06-06DOI: 10.1186/1758-3284-4-30
Zaid Hamdoon, Waseem Jerjes, Raed Al-Delayme, Colin Hopper
Photodynamic therapy (PDT) - the fourth modality - has been successfully used in the management of early and advanced pathologies of the head and neck. We studied the effect of this modality on a giant solitary neurofibroma of the neck. A 70-year-old Caucasian female presented with left neck pain and disfigurement associated with slight shortness of breath and dysphagia. Examination revealed a large mass in the neck with no neurovascular compromise. Magnetic resonance imaging (MRI) reported a heterogeneously enhancing mass extending from the left angle of the mandible to the base of the neck. A core biopsy was performed and histopathological examination revealed a disorganised array of peripheral nerve fascicles. The patient elected to receive photodynamic therapy as the primary intervention. The multi-disciplinary meeting approved the treatment plan. The photosensitizing agent was mTHPC (0.15 mg/kg), which was systemically administered 96-hours prior to ultrasound (US)-guided light delivery to the mass, which was undertaken under general anaesthesia. Recovery was uneventful. Post-PDT follow-up showed that the patient's pain, dysphagia and shortness of breath issues had improved. The disfigurement of the neck caused by the mass was no longer a problem. Three months post-PDT, MRI revealed a significant reduction in the neurofibroma size. PDT was proven as a successful primary intervention for this pathology. However, higher evidence-based studies are required before this therapy can be proposed as a replacement to any of the other conventional therapies.
{"title":"Solitary giant neurofibroma of the neck subjected to photodynamic therapy: case study.","authors":"Zaid Hamdoon, Waseem Jerjes, Raed Al-Delayme, Colin Hopper","doi":"10.1186/1758-3284-4-30","DOIUrl":"https://doi.org/10.1186/1758-3284-4-30","url":null,"abstract":"<p><p>Photodynamic therapy (PDT) - the fourth modality - has been successfully used in the management of early and advanced pathologies of the head and neck. We studied the effect of this modality on a giant solitary neurofibroma of the neck. A 70-year-old Caucasian female presented with left neck pain and disfigurement associated with slight shortness of breath and dysphagia. Examination revealed a large mass in the neck with no neurovascular compromise. Magnetic resonance imaging (MRI) reported a heterogeneously enhancing mass extending from the left angle of the mandible to the base of the neck. A core biopsy was performed and histopathological examination revealed a disorganised array of peripheral nerve fascicles. The patient elected to receive photodynamic therapy as the primary intervention. The multi-disciplinary meeting approved the treatment plan. The photosensitizing agent was mTHPC (0.15 mg/kg), which was systemically administered 96-hours prior to ultrasound (US)-guided light delivery to the mass, which was undertaken under general anaesthesia. Recovery was uneventful. Post-PDT follow-up showed that the patient's pain, dysphagia and shortness of breath issues had improved. The disfigurement of the neck caused by the mass was no longer a problem. Three months post-PDT, MRI revealed a significant reduction in the neurofibroma size. PDT was proven as a successful primary intervention for this pathology. However, higher evidence-based studies are required before this therapy can be proposed as a replacement to any of the other conventional therapies.</p>","PeriodicalId":49195,"journal":{"name":"Head and Neck Optical Diagnostics Society","volume":"4 ","pages":"30"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1758-3284-4-30","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30670821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-01-01Epub Date: 2012-04-26DOI: 10.1186/1758-3284-4-15
Jed J Jacobson, Joel B Epstein, Frederick C Eichmiller, Teresa B Gibson, Ginger S Carls, Emily Vogtmann, Shaohung Wang, Barbara Murphy
Background: Head and neck cancers are of particular interest to health care providers, their patients, and those paying for health care services, because they have a high morbidity, they are extremely expensive to treat, and of the survivors only 48% return to work. Consequently the economic burden of oral cavity, oral pharyngeal, and salivary gland cancer (OC/OP/SG) must be understood. The cost of these cancers in the U.S. has not been investigated.
Methods: A retrospective analysis of administrative claims data for 6,812 OC/OP/SG cancer patients was undertaken. Total annual health care spending for OC/OP/SG cancer patients was compared to similar patients without OC/OP/SG cancer using propensity score matching for enrollees in commercial insurance, Medicare, and Medicaid. Indirect costs, as measured by short term disability days were compared for employed patients.
Results: Total annual health care spending for OC/OP/SG patients during the year after the index diagnosis was $79,151 for the Commercial population. Health care costs were higher for OC/OP/SG cancer patients with Commercial Insurance ($71,732, n = 3,918), Medicare ($35,890, n = 2,303) and Medicaid ($44,541, n = 585) than the comparison group (all p < 0.01). Commercially-insured employees with cancer (n = 281) had 44.9 more short-term disability days than comparison employees (p < 0.01). Multimodality treatment was twice the cost of single modality therapy. Those patients receiving all three treatments (surgery, radiation, and chemotherapy) had the highest costs of cost of care, from $96,520 in the Medicare population to $153,892 in the Commercial population.
Conclusions: In the U.S., the cost of OC/OP/SG cancer is significant and may be the most costly cancer to treat in the U.S. The results of this analysis provide useful information to health care providers and decision makers in understanding the economic burden of head and neck cancer. Additionally, this cost information will greatly assist in determining the cost-effectiveness of new technologies and early detection systems. Earlier identification of cancers by patients and providers may potentially decrease health care costs, morbidity and mortality.
背景:头颈癌是卫生保健提供者、患者和支付卫生保健服务的人特别感兴趣的问题,因为头颈癌发病率高,治疗费用极其昂贵,幸存者中只有48%重返工作岗位。因此,必须了解口腔、口腔咽部和唾液腺癌(OC/OP/SG)的经济负担。在美国,这些癌症的成本尚未被调查。方法:回顾性分析6812例OC/OP/SG癌症患者的行政索赔资料。使用商业保险、医疗保险和医疗补助入选者的倾向评分匹配,将OC/OP/SG癌症患者的年度医疗保健总支出与无OC/OP/SG癌症的类似患者进行比较。以短期残疾天数衡量的间接成本对受雇患者进行了比较。结果:商业人群在指标诊断后一年内OC/OP/SG患者的年度医疗保健总支出为79,151美元。医疗费用高了OC / OP / SG癌症患者与商业保险(71732美元,n = 3918)、医疗保险(35890美元,n = 2303)和医疗补助(44541美元,n = 585)比对照组(所有p结论:在美国,OC / OP / SG癌症的成本很重要,可能是最昂贵的癌症治疗在美国这个分析的结果为卫生保健提供者提供有用的信息,决策者在理解头部和颈部癌症的经济负担。此外,这些费用资料将大大有助于确定新技术和早期检测系统的成本效益。患者和提供者及早发现癌症可能会降低医疗保健费用、发病率和死亡率。
{"title":"The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, Medicare, and Medicaid.","authors":"Jed J Jacobson, Joel B Epstein, Frederick C Eichmiller, Teresa B Gibson, Ginger S Carls, Emily Vogtmann, Shaohung Wang, Barbara Murphy","doi":"10.1186/1758-3284-4-15","DOIUrl":"https://doi.org/10.1186/1758-3284-4-15","url":null,"abstract":"<p><strong>Background: </strong>Head and neck cancers are of particular interest to health care providers, their patients, and those paying for health care services, because they have a high morbidity, they are extremely expensive to treat, and of the survivors only 48% return to work. Consequently the economic burden of oral cavity, oral pharyngeal, and salivary gland cancer (OC/OP/SG) must be understood. The cost of these cancers in the U.S. has not been investigated.</p><p><strong>Methods: </strong>A retrospective analysis of administrative claims data for 6,812 OC/OP/SG cancer patients was undertaken. Total annual health care spending for OC/OP/SG cancer patients was compared to similar patients without OC/OP/SG cancer using propensity score matching for enrollees in commercial insurance, Medicare, and Medicaid. Indirect costs, as measured by short term disability days were compared for employed patients.</p><p><strong>Results: </strong>Total annual health care spending for OC/OP/SG patients during the year after the index diagnosis was $79,151 for the Commercial population. Health care costs were higher for OC/OP/SG cancer patients with Commercial Insurance ($71,732, n = 3,918), Medicare ($35,890, n = 2,303) and Medicaid ($44,541, n = 585) than the comparison group (all p < 0.01). Commercially-insured employees with cancer (n = 281) had 44.9 more short-term disability days than comparison employees (p < 0.01). Multimodality treatment was twice the cost of single modality therapy. Those patients receiving all three treatments (surgery, radiation, and chemotherapy) had the highest costs of cost of care, from $96,520 in the Medicare population to $153,892 in the Commercial population.</p><p><strong>Conclusions: </strong>In the U.S., the cost of OC/OP/SG cancer is significant and may be the most costly cancer to treat in the U.S. The results of this analysis provide useful information to health care providers and decision makers in understanding the economic burden of head and neck cancer. Additionally, this cost information will greatly assist in determining the cost-effectiveness of new technologies and early detection systems. Earlier identification of cancers by patients and providers may potentially decrease health care costs, morbidity and mortality.</p>","PeriodicalId":49195,"journal":{"name":"Head and Neck Optical Diagnostics Society","volume":" ","pages":"15"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1758-3284-4-15","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40185702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Stefan Gerber, Carole Gengler, Klaus W Grätz, Astrid L Kruse
Background: Taking intraoperative frozen sections (FS) is a widely used procedure in oncologic surgery. However so far no evidence of an association of FS analysis and premalignant changes in the surgical margin exists. Therefore, the aim of this study was to evaluate the impact of FS on different categories of the final margins of squamous cell carcinoma (SCC) of the oral cavity and lips.
Methods: FS, pT-stage, grading, and tumor localization of 178 patients with SCC of the oral cavity and lips were compared by uni- and multivariate analysis in patients with positive, dysplastic and negative surgical margin status.
Results: Performed on 111 patients (62.4%), intraoperative FS did not have any statistically significant influence on final margin status, independent of whether it was positive (p = 0.40), dysplastic (p = 0.70), or negative (p = 0.70). Positive surgical margins in permanent sections were significantly associated with pT4-tumors (OR 5.61, p = 0.001). The chance for negative margins in permanent sections was significantly higher in tumors located in the tongue (OR 4.70, p = 0.01).
Conclusions: Our data suggests that intraoperative FS in SCC can be useful in selected cases. However it is not advisable as a routine approach.
背景:术中冰冻切片(FS)是肿瘤外科手术中广泛使用的一种方法。然而,到目前为止,还没有证据表明FS分析与手术边缘的癌前病变存在关联。因此,本研究的目的是评估FS对口腔和唇部鳞状细胞癌(SCC)不同类型终缘的影响。方法:对178例口腔和唇部鳞状细胞癌患者的FS、pt分期、分级和肿瘤定位进行单因素和多因素分析,比较手术缘状态阳性、发育不良和阴性患者的FS、pt分期、分级和肿瘤定位。结果:111例(62.4%)患者术中FS对最终切缘状态的影响无统计学意义,与阳性(p = 0.40)、发育不良(p = 0.70)、阴性(p = 0.70)无关。永久切片的手术切缘阳性与pt4肿瘤显著相关(OR 5.61, p = 0.001)。舌部肿瘤永久切片出现阴性切缘的几率显著高于舌部肿瘤(OR 4.70, p = 0.01)。结论:我们的数据表明术中SCC的FS在某些病例中是有用的。然而,不建议将其作为常规方法。
{"title":"The impact of frozen sections on final surgical margins in squamous cell carcinoma of the oral cavity and lips: a retrospective analysis over an 11 years period.","authors":"Stefan Gerber, Carole Gengler, Klaus W Grätz, Astrid L Kruse","doi":"10.1186/1758-3284-3-56","DOIUrl":"https://doi.org/10.1186/1758-3284-3-56","url":null,"abstract":"<p><strong>Background: </strong>Taking intraoperative frozen sections (FS) is a widely used procedure in oncologic surgery. However so far no evidence of an association of FS analysis and premalignant changes in the surgical margin exists. Therefore, the aim of this study was to evaluate the impact of FS on different categories of the final margins of squamous cell carcinoma (SCC) of the oral cavity and lips.</p><p><strong>Methods: </strong>FS, pT-stage, grading, and tumor localization of 178 patients with SCC of the oral cavity and lips were compared by uni- and multivariate analysis in patients with positive, dysplastic and negative surgical margin status.</p><p><strong>Results: </strong>Performed on 111 patients (62.4%), intraoperative FS did not have any statistically significant influence on final margin status, independent of whether it was positive (p = 0.40), dysplastic (p = 0.70), or negative (p = 0.70). Positive surgical margins in permanent sections were significantly associated with pT4-tumors (OR 5.61, p = 0.001). The chance for negative margins in permanent sections was significantly higher in tumors located in the tongue (OR 4.70, p = 0.01).</p><p><strong>Conclusions: </strong>Our data suggests that intraoperative FS in SCC can be useful in selected cases. However it is not advisable as a routine approach.</p>","PeriodicalId":49195,"journal":{"name":"Head and Neck Optical Diagnostics Society","volume":"3 ","pages":"56"},"PeriodicalIF":0.0,"publicationDate":"2011-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1758-3284-3-56","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30357454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
There is a paucity of publications detailing how to deal with the difficult thyroid cancer. When compared to other cancers, it is relatively rare with several histopathological subtypes which run differing clinical courses and respond to different therapies. It is a condition predominately treated by specifically trained General and now ENT surgeons who already have a thorough knowledge of vocal fold assessment and rehabilitation as well as emergency airways management both to avoid and treat common complications should they occur.Good surgery involves a team effort to produce good results consistently. All members of the team are essential to quality service delivery. Communication with the team and the patient is paramount. We describe our approach to the difficult thyroid.
{"title":"How to do it: the difficult thyroid.","authors":"Tahwinder Upile, Waseem Jerjes, Jaspal Mahil, Hitesh Tailor, Ramkishan Balakumar, Anuja Rao, Yassar Qureshi, Iain Bowman, Suchana Mukhopadhyay","doi":"10.1186/1758-3284-3-54","DOIUrl":"https://doi.org/10.1186/1758-3284-3-54","url":null,"abstract":"<p><p>There is a paucity of publications detailing how to deal with the difficult thyroid cancer. When compared to other cancers, it is relatively rare with several histopathological subtypes which run differing clinical courses and respond to different therapies. It is a condition predominately treated by specifically trained General and now ENT surgeons who already have a thorough knowledge of vocal fold assessment and rehabilitation as well as emergency airways management both to avoid and treat common complications should they occur.Good surgery involves a team effort to produce good results consistently. All members of the team are essential to quality service delivery. Communication with the team and the patient is paramount. We describe our approach to the difficult thyroid.</p>","PeriodicalId":49195,"journal":{"name":"Head and Neck Optical Diagnostics Society","volume":"3 ","pages":"54"},"PeriodicalIF":0.0,"publicationDate":"2011-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1758-3284-3-54","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30347892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Vascuologenesis is the de novo establishment of blood vessels and vascular networks from mesoderm-derived endothelial cell precursors (angioblasts). Recently a novel mechanism, by which some genetically deregulated and aggressive tumour cells generate "micro-vascular" channels without the participation of endothelial cells and independent of angiogenesis, has been proposed. This has been termed "vasculogenic mimicry" and has implications beyond angiogenesis and adds another layer of complexity to the current concept for the generation of tumour micro-circulation. We suggest this is common phenomenon in head and neck squamous cell carcinoma (HNSCC) cell lines and other aggressive tumour cell lines. We present experimental evidence of vasculogenic mimicry in HNSCC cell lines and compare them with other tumours and a positive control vascular cell line.
Materials and methods: The cell lines used were HUVEC, HN 2a, 2b (primary and metastatic tongue base squamous carcinoma cell line), HCT116 (colonic carcinoma cell line) and DU145 (prostate carcinoma cell line).Pilot experiments were undertaken to assess growth of a bank of tumour cell lines on (growth factor reduced) matrigel (Sigma) with standard media (DMEM with 10% Fetal Calf Serum).A functional growth assay was performed by preparing the appropriate cell suspension in serum free medium plated onto either bare plastic or a well pre-coated with growth factor reduced type 4 collagen analogues.Phase contrast photomicrographs were taken at 4 hours and 24 hours. Image analysis was performed; particular features of interest were two dimensional area (surrogate of growth and migration), branch points and end point measurements (surrogate of intercellular complexity).
Results: There were observable differences in growth of the cells on laboratory plastic and collagen matrix. Tumour cells formed capillary like networks similar to HUVEC cells. Metastatic HNSCC cells lines were found to have vasculogenic properties similar to HUVEC cell lines when compared to cell lines from their corresponding primary tumour. The endothelial growth factor antibodies used did not inhibit or stimulate cell growth when compared to control but did discourage vascular mimicry. Other tumour cell lines also displayed this property.
Discussion: Tumour "vasculogenic mimicry" must still be regarded as a controversial issue whose existence is not proven. The clinical importance of this phenomenon however, is that it does explain the lack of complete efficacy of current anti-angiogenic treatments due to the added layer of complexity. It provides a feasible mechanism of early tumour vascular supply which can co-exist and incorporate with later angiogenic mechanisms. We suggest that "vasculogenic mimicry" maybe a common neoplastic phenomena which appears to also be dictated by the cells micro-environment. Its existence also suggests a f
{"title":"Vascular mimicry in cultured head and neck tumour cell lines.","authors":"Tahwinder Upile, Waseem Jerjes, Hani Radhi, Mohammed Al-Khawalde, Panagiotis Kafas, Seyed Nouraei, Holger Sudhoff","doi":"10.1186/1758-3284-3-55","DOIUrl":"https://doi.org/10.1186/1758-3284-3-55","url":null,"abstract":"<p><strong>Introduction: </strong>Vascuologenesis is the de novo establishment of blood vessels and vascular networks from mesoderm-derived endothelial cell precursors (angioblasts). Recently a novel mechanism, by which some genetically deregulated and aggressive tumour cells generate \"micro-vascular\" channels without the participation of endothelial cells and independent of angiogenesis, has been proposed. This has been termed \"vasculogenic mimicry\" and has implications beyond angiogenesis and adds another layer of complexity to the current concept for the generation of tumour micro-circulation. We suggest this is common phenomenon in head and neck squamous cell carcinoma (HNSCC) cell lines and other aggressive tumour cell lines. We present experimental evidence of vasculogenic mimicry in HNSCC cell lines and compare them with other tumours and a positive control vascular cell line.</p><p><strong>Materials and methods: </strong>The cell lines used were HUVEC, HN 2a, 2b (primary and metastatic tongue base squamous carcinoma cell line), HCT116 (colonic carcinoma cell line) and DU145 (prostate carcinoma cell line).Pilot experiments were undertaken to assess growth of a bank of tumour cell lines on (growth factor reduced) matrigel (Sigma) with standard media (DMEM with 10% Fetal Calf Serum).A functional growth assay was performed by preparing the appropriate cell suspension in serum free medium plated onto either bare plastic or a well pre-coated with growth factor reduced type 4 collagen analogues.Phase contrast photomicrographs were taken at 4 hours and 24 hours. Image analysis was performed; particular features of interest were two dimensional area (surrogate of growth and migration), branch points and end point measurements (surrogate of intercellular complexity).</p><p><strong>Results: </strong>There were observable differences in growth of the cells on laboratory plastic and collagen matrix. Tumour cells formed capillary like networks similar to HUVEC cells. Metastatic HNSCC cells lines were found to have vasculogenic properties similar to HUVEC cell lines when compared to cell lines from their corresponding primary tumour. The endothelial growth factor antibodies used did not inhibit or stimulate cell growth when compared to control but did discourage vascular mimicry. Other tumour cell lines also displayed this property.</p><p><strong>Discussion: </strong>Tumour \"vasculogenic mimicry\" must still be regarded as a controversial issue whose existence is not proven. The clinical importance of this phenomenon however, is that it does explain the lack of complete efficacy of current anti-angiogenic treatments due to the added layer of complexity. It provides a feasible mechanism of early tumour vascular supply which can co-exist and incorporate with later angiogenic mechanisms. We suggest that \"vasculogenic mimicry\" maybe a common neoplastic phenomena which appears to also be dictated by the cells micro-environment. Its existence also suggests a f","PeriodicalId":49195,"journal":{"name":"Head and Neck Optical Diagnostics Society","volume":"3 ","pages":"55"},"PeriodicalIF":0.0,"publicationDate":"2011-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1758-3284-3-55","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30347699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Waseem Jerjes, Tahwinder Upile, Hani Radhi, Colin Hopper
Controlling tumour margins in head and neck surgery is of the utmost importance in preventing loco-regional spread and distant metastasis, which will ultimately lead to a significant reduction in morbidity and mortality. We comment on the surgical margins in photodynamic therapy and photochemical internalization.
{"title":"Photodynamic therapy vs. photochemical internalization: the surgical margin.","authors":"Waseem Jerjes, Tahwinder Upile, Hani Radhi, Colin Hopper","doi":"10.1186/1758-3284-3-53","DOIUrl":"https://doi.org/10.1186/1758-3284-3-53","url":null,"abstract":"<p><p>Controlling tumour margins in head and neck surgery is of the utmost importance in preventing loco-regional spread and distant metastasis, which will ultimately lead to a significant reduction in morbidity and mortality. We comment on the surgical margins in photodynamic therapy and photochemical internalization.</p>","PeriodicalId":49195,"journal":{"name":"Head and Neck Optical Diagnostics Society","volume":"3 ","pages":"53"},"PeriodicalIF":0.0,"publicationDate":"2011-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1758-3284-3-53","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30344500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}